We are currently enrolling into a study for subjects narcolepsy type 1 with the following criteria:
Narcolepsy Study (Lower sodium-sodium oxybate):
- 18-week main study
- Optional 24-week open label extension study
- Placebo controlled
- History of >14 cataplexy attacks
in 2-week period on average
- 18-70 years of age